Article

Cloning and characterization of the major outer membrane protein gene (ompH) of Pasteurella multocida X-73.

Department of Avian Medicine, College of Veterinary Medicine, The University of Georgia, Athens 30602, USA.
Journal of Bacteriology (Impact Factor: 2.69). 01/1998; 179(24):7856-64.
Source: PubMed

ABSTRACT The major outer membrane protein (OmpH) of Pasteurella multocida X-73 was purified by selective extraction with detergents, followed by size exclusion chromatography. The planar lipid bilayer assay showed that OmpH has pore-forming function. The average single channel conductance in 1.0 M KCl was 0.62 nS. The gene (ompH) encoding OmpH has been isolated and sequenced by construction of a genomic library and PCR techniques. The coding region of this gene is 1,059 bp long. The predicted primary protein is composed of 353 amino acids, with a 20-amino-acid signal peptide. The mature protein is composed of 333 amino acids with a molecular mass of 36.665 kDa. The ompH gene encoding mature protein has been expressed in Escherichia coli by using a regulatable expression system. The ompH gene was distributed among 15 P. multocida serotypes and strain CU. Protection studies showed that OmpH was able to induce homologous protection in chickens. These findings demonstrate that OmpH is a protective outer membrane porin of strain X-73 and is conserved among P. multocida somatic serotypes.

0 Followers
 · 
102 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pasteurella multocida is one of the important animal pathogen causing widespread infections in various domestic animals. In swine, it causes severe respiratory diseases such as atrophic rhinitis and pneumonic pasteurellosis. To develop the efficient subunit vaccine against swine atrophic rhinitis, we investigated protective antibodies and humoral immunity of outer membrane protein H (OmpH) which is one of the major outer membrane proteins in P. multocida. Outer membrane fraction of P. multocida was immunologically detectable using antisera from both mice groups vaccinated by formalin-killed whole cells and by commercial vaccine. The expression vector for production of recombinant OmpH was constructed and the recombinant OmpH was expressed and purified from E. coli. Recombinant OmpH showed high antigenic and immunogenic properties in mice vaccination and ELISA with antisera.
    Korean Journal of Microbiology 01/2007; 43(1).
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Foi analisada a variabilidade antigênica e fenotípica de 22 cepas de Pasteurella multocida isoladas de pulmões de suínos com pneumonia e/ou pleurite. Os testes fenotípicos foram realizados pela determinação de características bioquímicas e sensibilidade a agentes antimicrobianos. Todos os isolados fermentaram manitol e sorbitol, mas nenhum arabinose; 14 foram capazes de metabolizar xilose, quatro trealose, dois dulcitol e um maltose. A análise destas características permitiu agrupar os isolados em 5 padrões bioquímicos distintos. Quanto à sensibilidade a nove agentes antimicrobianos, verificou-se grande variação, com apenas 50% dos isolados sensíveis a pelo menos sete dos nove antibióticos testados. Nenhum princípio ativo foi capaz de inibir todos os isolados. A melhor eficiência foi observada com a amoxicilina (30 mg); 72,7% dos isolados se mostraram sensíveis. A menor eficiência foi demonstrada pela espectinomicina (100 mg) com 45,5%. A caracterização antigênica consistiu na sorotipagem capsular e determinação de variabilidade do gene de proteína de membrana externa (ompH) pela reação em cadeia da polimerase (PCR) e digestão com cinco enzimas de restrição. Das 22 cepas, 21 foram compatíveis com sorotipo capsular A e uma com D. A caracterização do gene ompH agrupou os isolados em sete padrões distintos que apresentaram boa correlação com os testes bioquímicos.
    Pesquisa Veterinária Brasileira 09/2002; 22(3):97-103. DOI:10.1590/S0100-736X2002000300002 · 0.44 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recombinant outer membrane protein H (rOmpH) is a potential fowl cholera vaccine candidate. The present study was aimed at developing rOmpH formulations for intranasal administration. The rOmpH was purified and formulated with either Escherichia coli enterotoxin B (LTB) or CpG oligodeoxynucleotides (ODN) as an adjuvant. Antibody responses in chickens intranasally immunized with rOmpH in combination with two different adjuvants were significantly increased (P<0.05) post immunization. Chicken survival rates showed that rOmpH formulated with ODN and LTB elicited 90% and 70% protection, respectively. Our findings indicated that rOmpH formulated with ODN elicited protection better than that formulated with LTB. Therefore, the vaccines formulations in the present study can be considered new intranasal vaccine formulations for fowl cholera in chickens.

Full-text (2 Sources)

Download
11 Downloads
Available from
Sep 2, 2014